IRIS
DAVI', Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.031
EU - Europa 8.012
AS - Asia 5.557
SA - Sud America 326
Continente sconosciuto - Info sul continente non disponibili 31
AF - Africa 24
OC - Oceania 4
Totale 22.985
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.990
CN - Cina 1.954
UA - Ucraina 1.854
SG - Singapore 1.801
IE - Irlanda 1.538
TR - Turchia 1.398
SE - Svezia 960
GB - Regno Unito 819
IT - Italia 763
FR - Francia 628
DE - Germania 619
FI - Finlandia 391
RU - Federazione Russa 300
BR - Brasile 288
IN - India 282
CZ - Repubblica Ceca 34
HK - Hong Kong 32
AT - Austria 29
EU - Europa 26
CA - Canada 22
PL - Polonia 17
BE - Belgio 15
IL - Israele 13
IR - Iran 12
NL - Olanda 11
AR - Argentina 8
IQ - Iraq 8
MX - Messico 8
EC - Ecuador 7
AZ - Azerbaigian 6
UZ - Uzbekistan 6
VN - Vietnam 6
BD - Bangladesh 5
CL - Cile 5
CO - Colombia 5
EG - Egitto 5
MA - Marocco 5
PK - Pakistan 5
RO - Romania 5
TW - Taiwan 5
VE - Venezuela 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BZ - Belize 4
DZ - Algeria 4
JP - Giappone 4
LT - Lituania 4
CR - Costa Rica 3
DK - Danimarca 3
LB - Libano 3
PY - Paraguay 3
RS - Serbia 3
UY - Uruguay 3
ZA - Sudafrica 3
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
ES - Italia 2
GR - Grecia 2
KE - Kenya 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
EE - Estonia 1
HU - Ungheria 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
QA - Qatar 1
SA - Arabia Saudita 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 22.985
Salva come PNG Salva come JPEG
Città #
Jacksonville 2.153
Dublin 1.529
Chandler 1.452
Singapore 1.272
Princeton 744
Izmir 731
Southend 656
Nanjing 603
Wilmington 383
Cambridge 340
Ashburn 306
Santa Clara 302
Beijing 299
Dearborn 298
Altamura 295
Nanchang 224
The Dalles 165
Ann Arbor 164
Chieti 124
Boardman 111
Hebei 103
Shenyang 103
Woodbridge 101
Tianjin 91
Kunming 88
New York 75
Jiaxing 69
Washington 69
Grevenbroich 67
Los Angeles 66
Moscow 64
Helsinki 57
Norwalk 56
Changsha 53
Munich 37
Hangzhou 35
Augusta 31
Orange 31
Hong Kong 30
Brno 28
Jinan 28
Changchun 27
Lanzhou 26
San Mateo 25
Ningbo 22
Houston 20
Seattle 20
Falls Church 19
Leawood 18
Pescara 18
São Paulo 18
Toronto 18
Rome 17
Shanghai 17
Brussels 15
Zhengzhou 13
Frankfurt am Main 11
Guangzhou 11
Haikou 10
Hefei 10
Vienna 10
Auburn Hills 9
Milan 9
Brasília 8
Cedar Knolls 8
Fuzhou 8
Nuremberg 8
Pune 8
Rio de Janeiro 8
Tappahannock 8
Andover 7
Meylan 7
Bologna 6
Caserta 6
Curitiba 6
Dong Ket 6
Edinburgh 6
Hackney 6
Simi Valley 6
Taiyuan 6
Tashkent 6
Walnut 6
Baku 5
Belo Horizonte 5
Council Bluffs 5
Düsseldorf 5
London 5
Mountain View 5
Perugia 5
Piracicaba 5
Romola 5
Saint-prix 5
Salvador 5
Taipei 5
Taizhou 5
Wuhan 5
Araxá 4
Catania 4
Chengdu 4
Chongqing 4
Totale 14.012
Salva come PNG Salva come JPEG
Nome #
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 141
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 129
Pentraxin 3 and platelet activation in obese patients after gastric banding 129
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 128
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 127
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 122
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 119
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 119
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 116
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 116
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 114
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 114
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 107
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 106
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 106
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients. 106
Platelets and Diabetes 105
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 103
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 103
Determinants of platelet activation in hypertensives with microalbuminuria. 102
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 102
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 101
Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards 101
Platelets and diabetes mellitus 101
Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis 101
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 100
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 100
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 100
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 100
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 99
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 98
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 98
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 97
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 97
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 97
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 96
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 96
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 96
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 95
Increased soluble CD40L levels in cystic fibrosis 95
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 95
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 94
Coagulation and infective endocarditis: sooner or later 94
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 94
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 93
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 93
Antipsychotic prescription and mortality in hospitalized older persons 92
A comparison of five maintenance therapies for reflux esophagitis 91
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 91
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 91
Platelet activation in obesity and metabolic syndrome. 90
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 90
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 90
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 90
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 90
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 89
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 89
Atherothrombotic disease and the metabolic syndrome. 89
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 89
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 89
Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients: Results from the REPOSI study 89
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 88
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 88
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 88
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 88
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 87
Insulin resistance as a determinant of platelet activation in obese women. 87
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 87
Soluble forms of RAGE in internal medicine. 87
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 86
Endothelial dysfunction and oxidative stress in arterial hypertension. 85
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 85
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 85
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 85
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 85
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 84
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 83
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 82
Leptin increase is associated with markers of the hemostatic system in obese healthy women 82
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 82
Diabetes mellitus and thrombosis 81
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 80
Increased levels of soluble P-selectin in hypercholesterolemic patients 80
Soluble RAGE in type 2 diabetes: association with oxidative stress. 80
Homocysteine modulates the CD40/CD40L system 80
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 80
Thromboxane-Dependent Platelet Activation After Gastric Banding for Obesity. 80
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 79
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 79
Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach 79
Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever 79
Short term vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects 78
Determinants of platelet activation in hypertensives with microalbuminuria. 78
What do we know about obesity? 78
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 77
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 77
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 77
Oxidative stress in chronic vascular disease: From prediction to prevention 77
The left atrial appendage: from embryology to prevention of thromboembolism 77
Thrombin as a common downstream target blocking both platelet and monocyte activation 76
Totale 9.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.557
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020490 0 0 0 0 0 0 0 0 0 0 466 24
2020/20212.055 391 12 386 11 120 487 24 20 157 326 39 82
2021/20221.396 23 29 11 218 104 20 22 121 121 53 216 458
2022/20234.428 432 654 236 425 385 931 302 299 529 45 97 93
2023/20241.949 139 78 136 50 118 633 504 72 18 33 14 154
2024/20253.844 463 1.089 862 67 77 134 82 223 519 207 121 0
Totale 24.082